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Introduction
Breast cancer (BC) is a leading women’s health paradigm
with a considerable burden (Alberg and Helzlsouer, 1997)
and a family history (FH) of BC in close relatives is a well
known risk factor for the disease (Kelsey and Gammon,
1990). Cancer involvement of several members of some
families is an established fact, dating back to at least the
1800s (Newman et al., 1997; Broca, 1866), but the first
empiric demonstration that women with an FH of BC are
more likely to become afflicted with the disease and
eventually die from it was not published until 70 years ago
(Lane-Claypon, 1926). Since then, an ever-increasing body
of evidence has put forward FH of the BC as one of the
most consistently documented risk factors of the disease
(Newman et al., 1997). Across all ages, women with BC
are, on average, 2 to 3 times more likely to have an FH of
the disease in a 1st-degree relative than controls (Kelsey,1979;
Kelsey and Gammon, 1990; Eby et al.,1994). This may be
due partly to the fact that relatives tend to be exposed to the
same environmental risk factors, but also an inheritable
(genetic) susceptibility might be involved (Houlston and
Peto, 1996).
Although FH has long been recognized as the principal
risk factor in BC, high numbers of different afflicted relatives
are only observed in rare families, and many patients are
found to have no close affected relative (Margaritte-Jeannin
et al.,1995). All in all, segregation analysis has revealed a
mixed nature for BC, in which approximately 5% to 10% of
cases are regarded as inherited cases, and remaining, as
sporadic cases (Bishop et al.,1988; Claus et al.,1991; Kelsell
et al.,1993; Newman et al., 1988; Williams and Anderson,
1984). The statement of familial aggregation comes from
descriptive studies of large extended pedigrees containing
multiple family members with BC alone, or in conjunction
with other cancers (Anderson, 1974; Lynch et al., 1974).
There are some factors which are believed to be linked
to this familial segregation of BC. For example, age at onset
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of BC in relatives and whether the relative affected is the
mother and/or sister(s) may give rise to different BC risks
(Peto, 1980).
The age of onset is believed to be varied among inherited
and sporadic cases. The incidence of BC increases with
increasing age and is believed to be relatively rare below
the age of 40 years. Data from genetic epidemiology studies
of BC are likely to be deficient in numbers of early-onset
cases (Eccles et al., 1994), but familial BCs generally strike
at a much earlier age (Margaritte-Jeannin et al.,1995). Also,
the risk of BC in 1st degree relatives is greatest with those
with an FH of BC with an early age of onset (Ottman et al.,
1986; Claus et al., 1990). Some other studies have found
that an FH of BC is a stronger risk factor at younger proband
age (Claus et al., 1990; Brinton et al., 1982; Calle et al.,1993),
although the evidence is not consistent (Colditz et al., 1993;
Parazzini et al., 1993; Peto et al., 1996, Atri et al., 2003).
We have found a lack of any association between early onset
of breast cancer and numbers of affected relatives in an
Iranian population (Atri et al., 2003).
The association between BC and an FH of the disease is
generally stronger considering women with bilateral disease
(Newman et al., 1997; Ottman et al., 1986; Slattery and
Kerber, 1993; Tulinius et al., 1992; Byrne et al., 1991),
together with the above-mentioned earlier onset of disease
(measured either by age or menopausal status at diagnosis)
(Ottman et al., 1986; Claus et al., 1990; Colditz et al., 1993;
Slattery and Kerber, 1993; Tulinius et al., 1992; Schwartz et
al., 1985). Moreover, when FH includes more distant
relatives (e.g. 2nd or 3rd degree), the association is usually
weaker (Slattery and Kerber, 1993; Tulinius et al., 1992;
Byrne et al., 1991; Schwartz et al., 1985), and when it
includes more than one 1st-degree relative with BC, the
association becomes stronger still (Claus et al., 1990;
Tulinius et al., 1992; Byrne et al., 1991; Schwartz et al.,
1985).
Slightly higher relative risks (3 to 4) are also reported
for ovarian cancer in families with a history of BC (Amos
and Struewing, 1993). Further more, FH of colon, prostate,
ovarian and other cancers including gynecological cancers
has been associated with an increased risk of BC in some
but not all studies (Peto, 1980; Parazzini et al., 1993;
Thompson and Schildkraut, 1990; Anderson et al., 1992;
Tulinius et al., 1992; Anderson and Badzioch, 1993; Goldgar
et al., 1994; Teare et al., 1994).
Most research has been conducted in North America and
north European countries. The familial predisposition to BC
however may have different genetic and environmental
correlation in different populations including the prevalence
of various susceptibility genes and the impact of various
environmental factors (Negri et al., 1997).
In a previous report (Negri et al., 1997), regarding the
relation between FH of cancer in first degree relatives and
the risk of BC on the basis of large case-control study, 2569
BC afflicted women with the age ranging from 23 to 74
(with mean of 55) were analyzed.
A significant increase in BC was observed with an FH
of intestinal (OR 1.32) and BC (OR 2.38). Seven cases and
one control reported a history of gallbladder cancer in first-
degree relatives (OR 8.57). FH of other cancers was not
related to BC risk, although a not very significant correlation
was noted for ovary (OR 1.29), kidney (1.70), lymphoma
(1.71) and leukemia (1.35) (Negri et al., 1997). The OR of
BC with reference to FH of BC in different strata of the age
of the probands and other selected co-variants was compared.
No trend with age at diagnosis was evident and the highest
OR was noted at age 60 or over, followed by group below
45 years (Negri et al., 1997).
The OR of BC according to the type of relative with
history of BC and the age of the relative was also considered.
Compared with women with no history of BC in first-degree
relatives, those with only the mother affected had an OR of
2.26, those with only sister had an OR of 2.56, and those
with both the mother and sister affected had an OR of 2.36.
Relative to women with no first-degree relatives with BC,
those with a first-degree relative with BC diagnosed below
age 40 had an OR of 3.51, while those with relatives with
BC diagnosed above age of 40 had an OR of 2.17 (Negri et
al., 1997).
The mortality in mothers and sisters for specific causes
of death is presented in a report of 740 index cases of BC
and their pedigrees. There was no marked overall excess
mortality for cancers other than BC (51 death, significant
mortality ratio (SMR) 1.26, p=0.13) although there was
stronger evidence of an excess below age 50 (20 death, SMR
2.01. p=0.007). Cancers of the cervix, endometrial, and lung
were all significantly elevated below age 50 (SMRs 3.47,
10.53, and 5.88 respectively) (Anderson et al., 1992). This
study showed 70 BC cases among 1568 mothers and sisters
(a frequency of 0.0446) (Anderson et al., 1992).
The observed excess of lung cancer and uterine cancer
which were particularly below age 50 were somewhat
surprising (Schildkraut et al., 1989).
Excess of endometrial cancer is reported in relatives of
BC cases diagnosed under age of 40 (Peto et al., 1996).
However in the same study, no excess of lung cancer or
cervical cancer among the BC relatives was observed.
Most of the pedigree information is obtained on the basis
of probands’ claims, although cases may have been
confirmed by hospital records, or death certificates
(Anderson et al., 1992). The more extensive the FH, the
greater certainly will be about the carrier status. This is well
illustrated by the family studies in previous reports
(Margaritte-Jeannin et al.,1995).  Also, it has been suggested
that age of onset provides limited information on the carrier
status of affected individuals and most be used with caution
in genetic counseling (Margaritte-Jeannin et al.,1995).
In most of the studies, the pedigrees are confined to first-
degree and at most, second-degree relatives. But in Iran,
close relationship among family members enables us to rely
more on the information about more distant relatives (3rd
and 4th degree relatives, e.g. first, second and even third
cousin). Thus Iranian family members are usually well aware
of familial events, including diseases, births and deaths.
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Patients & Methods
Cases included 542 Iranian primary BC patients,
diagnosed between 1994 and 1999. They didn’t have any
history of a previous malignancy and they all received
standard treatment. Patients with stage 4 disease were
excluded to minimize possible interference between patients’
disease course and obtaining family history data.
Patients and their accompanying relatives were initially
interviewed by our geneticist to draw the basic pedigrees.
Subsequently, further interviews with patients and their
relatives were constructed to increase the details and
reliability of the pedigrees.
The pedigrees were drawn upon patients’ and their
relatives’ claims, but whenever possible, medical documents
and reports were used to substantiate these claims.
Data regarding patients’ characteristics, their familial
history, and type, age at diagnosis, degree, parental line, and
generation of cancer afflicted relatives were extracted from
the pedigrees and entered to SPSS (version 10) program to
construct the database, which was subsequently analyzed.
Probands’ generation was considered as 3rd generation.
Analysis was performed with both inclusion and exclusion
of the probands. Whenever cited, ranges are mean±2SE.
Results
In order to investigate the different cancer involvement
patterns among the breast cancer (BC) afflicted patients’
blood relatives, and to reveal the possible relations, we
analyzed a comprehensive database of 542 BC patients’
families with emphasis on the breast and other frequent
malignancies (OM) and their occurrence according to the
different generations, degrees, and parental lines. Probands
were put in the 3rd  (Figure 1) generation.
The mean age of the patients was 48.9±0.97. Of these
patients, 29.9 and 53.9% had a positive FH of breast and
other malignancies respectively. Data was available for a
total of 6220 blood relatives (Table 1).
A total of 213 BC cases were reported in these families
(542 probands excluded) with the maximum of 4 BC cases
in individual families. Frequencies and standardized ratios
are showed in Table 2.
These cases were observed across 1st to 4th generations
and among 1st to 4th degree relatives (Table 3). Breast cancer
occurrences in first, second and third generation and in first,
second and third degree relatives were associated (P< 0.001).
Mean number of breast cancers was nearly double in
maternal-lines versus paternal-line (0.17 vs. 0.09, P= 0.002)
(First degree relatives excluded).
Considering the OM’s, a total of 477 cases were reported
in the families, with the gastric (63), lung (49), uterus (44),
hematopoeitic system (40), brain (34), colorectal (30),
esophagus (28), prostate (28), liver (25), and lymphoid tissue
(23) cancers as the leading malignancies. Frequencies and
standardized ratios are showed in Table 4.
The mean age of the BC afflicted relatives in 1st, 2nd, 3rd,
4th and all generations at the time of diagnosis was 55, 51.92,
41.14, 41.95, and 47.14 years old respectively.
Of the BC afflicted relatives, 121, 50, 32, and 8 cases
belonged to the maternal, paternal, sister and brother lines
respectively, and the 1st degree relatives in these lines (i.e.
mother, father, sister, and brother) consisted of 28, 1, 33,
and 0 cases respectively.
Considering the OMs, gastric, lung, uterus,
hematopoeitic system, brain, colorectal, esophagus, prostate,
liver, lymphoid tissue (Lymphoma), and ovary cancers were
selected. The number of cases according to parental line is
showed in Table 5.
The distribution of relatives’ OMs and frequencies of
different malignancies across 1st, 2nd, 3rd, 4th, and all
generations are presented in table 6.
Of all the OM afflicted relatives, 93, 103, 75, and 5 cases
belonged to the 1st, 2nd, 3rd, and 4th degree relatives. The
Table 1. Total Studied Relatives. (Bold numbers indicate patients themselves.)
1st Generation 2nd Generation 3rd Generation 4th Generation 5th Generation Total
Male 248 668 1121+6 793 68 2898+6
Female 267 734 1423+536 835 63 3322+536
Total 515 1402 2544+542 1628 131 6220+542
Figure 1. Patient  Pedigrees
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distribution of cancers among different relatives is presented
in table 7.
We also took a look at the age of cancer afflicted relatives
in different generations.  In order to take probands’ age and
its possible effects as a general risk factor of cancer
development into account, distribution of malignancies were
compared according to probands’ age. Considering the OMs,
the mean age of the FH(+) and FH(-) probands was 49.70
and 48.43 (Mean difference 1.2709, 95% CI of the difference
-.6925 to 3.2343). The mean age of the probands according
to each type of cancers is presented in table 8.
Discussion
A positive family history (FH) of Breast Cancer (BC) is
noted in approximately 20-30 % of the BC afflicted patients
in general studies. The importance of FH as a risk factor
(and as showed by the authors elsewhere, a possible
prognostic factor (Atri et al., 2002)) is generally recognized.
In this regard, we analyzed a database of 542 BC family,
encompassing a total of 6762 individuals, including 542 BC
afflicted probands.
Accordingly, 29.9% of our studied probands had a
positive FH of BC. Also a positive FH of the malignancies
other than BC (OM), and all cancers was noted in 53.9%
and 64.3% of the families respectively. These crude values
demonstrate a considerable overlap between having an FH
of BC and having an FH of OM (chi2=102.490, DF=28,
p<0.001).
The mean age of the probands was 48.9851±0.9688 years
old. The first question to address was whether the positive
FH of BC/OM is somehow related to the age of the probands.
In other words, considering the age as the most important
general single risk factor of cancer, we wanted to determine
the relation between the age of the probands and the FH of
cancers, since it would be expectable that with increasing
the probands’ age, the mean relatives’ age also increase,
which would by itself result in higher cancer incidence.
Using t-test, we found no difference between the mean
age of the patients with and without an FH of BC and OM
(49.48 versus 48.96 for BC, and 49.70 versus 48.53 for OM).
The mean ages of the patients with and without FH of
different cancers are presented in Table 8, and as it shows,
Table 3. Frequency of BC Among Relatives and Across
Generations.
1st Gen. 2nd Gen. 3rd Gen. 4th Gen.  Total
1st Degree - 28 32 8 68
2nd Degree 5 49 6 7 67
3rd Degree 16 13 40 4 73
4th Degree 0 0 3 2 5
Total 21 90 81 21 213
Table 4. Frequency of OM According to Sex and Generation. (Numbers in parentheses indicate ratios with probands
included in the denominator.)
Total No. of Cases                                  Standardized Frequencies (ratios)
No. of Cases to Total No. of Cases to Total No. of Cases to Total
Male Relatives* Female Relatives* Relatives*
1st Generation 61 0.24596 0.22846 0.11844
2nd Generation 239 0.35778 0.32561 0.17047
3rd Generation 131 0.11685 (0.116) 0.09205 (0.067) 0.05149 (0.042)
4th Generation 43 0.05422 0.05149 0.02641
5th Generation 3 0.04411 0.05149 0.02641
All 477 0.16459 (0.164) 0.14358 (0.124) 0.07668 (0.071)
* In the same generation.
Table 2. Frequency of BC According to Sex and Generation. (Numbers in parentheses indicate ratios with probands
included.)
Total No. of Cases Standardized Ratios
No. of Cases to Total No. of Cases to Total    No. of Cases to Total
Male Relatives* Female Relatives*      Relatives*
1st Generation 21 0.085 0.079 0.041
2nd Generation 90 0.135 0.123 0.064
3rd Generation 81 (623) 0.072 (0.553) 0.057 (0.318) 0.032 (0.092)
4th Generation 21 0.026 0.025 0.013
5th Generation 0 0 0 0
All 213 (755) 0.073 (0.260) 0.064 (0.196) 0.034 (0.112)
* In the same generation.
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the only significant difference exists between the mean age
of the probands with and without an FH of prostate cancer
(54.65 versus 48.83). Also, there was no significant
correlation between the mean age of the probands, and the
mean age of the relatives.
It has been widely accepted that the familial BC cases,
tend to manifest in younger age (early-onset BC).
Interestingly, this consensus is in contrast with our findings.
In our studied BC probands (n=542), 11.99% of cases had
their disease diagnosed at or before the age of 36. This
percent is considerably higher in comparison with other
studies which consider early onset BC as a relatively rare
occurring. We noted a positive FH of BC in only 18.5% of
these cases which was even much less than the general FH(+)
ratio in all the probands regardless of their age. This finding
indicates the possibility that early-onset BC cases in our
country are less attributable to familial predispositions, and
puts forward the environmental factors as the prime cause.
A reported high number of different afflicted relatives is
observed in rare families (Margaritte-Jeannin et al.,1995).
The number of cancer afflicted relatives in our study is shown
in Table 9.
Total numbers of the relatives and sex ratios among
different  generations is presented in Table 1. It is surprising
Table 7. Distribution of Cancers According to the Degree of Family Relationship.
     1st Degree            2nd Degree             3rd Degree              4th Degree                 Total
Gastric 22 (34.9%) 26 (41.2%) 15 (23.8%) 0 (0%) 63
Lung 20 (40.8%) 17 (34.6%) 11 (22.4%) 1 (2%) 49
Uterus 13 (29.5%) 16 (36.3%) 13 (29.5%) 2 (4.5%) 44
Brain 12 (35.2%) 12 (35.2%) 9 (26.4%) 1 (2.9%) 34
Colorectal 8 (26.6%) 9 (30%) 12 (40%) 1 (3.3%) 30
Esophagus 5 (17.8%) 15 (53.3%) 8 (28.5%) 0 (0%) 28
Prostate 13 (46.4%) 8 (28.5%) 7 (25%) 0 (0%) 28
Table 5. Distribution of OMs According to Paternal Lines. (Numbers in parentheses indicate numbers of afflicted 1st
degree relatives.)
Type of Cancer      Maternal Line     Paternal Line         M/P*         Sister Line     Brother Line          S/B            Total
Gastric 33 (5) 24 (13) 1.37 (2.54) 4 (2) 2 (2) 2 (2/0) 63
Lung 15 (1) 31 (17) 0.48 (1) 1 (1) 2 (2) 0.5 (0/0) 49
Uterus 27 (9) 10   2.7 (1.8) 6 (6) 1 6 (0/1) 44
Leukemia 14 (3) 12 (4) 1.16 (1.37) 3 (2) 7 (0) 0.42 (0.14) 40
Brain 19 (2)   7 (1) 2.71 (2.83) 4 (3) 1 (0) 4 (1) 34
Colorectal 16 (1)   7 (1) 2.28 (2.5) 0 (0) 6 (6) 0/6 (0/0) 30
Esophagus 10 (1) 16 (2) 0.62 (0.64) 0 (0) 2 (2) 0/2 (0/0) 28
Prostate   6 16 (9) 0.37 (0.85) 0 4 (4) 0/4 (0/0) 28
Liver 10 (5) 12 (3) 0.83 (0.55) 1 (1) 2 (2) 0.5 (0/0) 25
Lymphoma 10 (3) 10 (4) 1 (1.16) 0 (0) 3 (3) 0/3 (0/0) 23
Ovary   1 (1)   1 1 (0/1) 2 2 1   7
* Numbers in parenthesis indicates ratios with first degree relatives excluded.
Table 6. Distribution of Different Cancers According to Generations.
Generation        1st       2nd       3rd      4th       All
No.  Freq. No.  Freq. No.  Freq. No.  Freq. No.  Freq.
Gastric 10 0.0194 41 0.0292 12 0.0038 0 0 63 0.0093
Lung 8 0.0155 29 0.0206 10 0.0032 2 0.0012 49 0.0072
Uterus* 6 0.0224 17 0.0231 20 0.0102 1 0.0011 44 0.0114
Leuk. 2 0.0038 8 0.0057 10 0.0032 15 0.0092 36 0.0053
Brain 2 0.0038 12 0.0085 16 0.0051 4 0.0024 34 0.0050
Color. 5 0.0097 16 0.0114 8 0.0025 1 0.0006 30 0.0044
Eso. 6 0.0116 15 0.0106 6 0.0019 1 0.0006 28 0.0041
Prost.* 5 0.0201 16 0.0239 6 0.0053 1 0.0012 28 0.0096
All 93 0.1805 103 0.0733 75 0.0237 5 0.0029 477 0.0704
* For the uterus and prostate cancers, denominator consists of the total relatives of the same sex.
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that the male/female (M/F) ratio in 3rd generation is
dramatically less than other generations (0.5752). This might
be partly explained because of the nature of our pedigrees
(based upon BC-probands who are mostly females), but by
exclusion of probands, still the same pattern persists (M/F
ratio = 0.7877).
Considering the number of BCs in pedigrees, 2nd
generation followed by 3rd generations showed highest crude
frequencies (542 BC probands excluded), and 3rd followed
by 2nd generations (the BC probands included). However,
the standardized ratios revealed the leading generations of
BC involvement to be 2nd and 1st (probands excluded); and
3rd and 2nd generations (probands included).
Therefore, by including the probands (Table 2), the
highest incidence is reflected in 3rd generation, and so a
cascade manifestation through the 1st to 3rd generations could
be noted.
When we considered the total number of relatives
through 1st to 4th generations, the same pattern was revealed,
but disparity between 1st & 2nd generations decreased (Table
2).
The most frequent BC involvement among 1st; 2nd; 3rd;
and 4th degree relatives was noted in 3rd; 2nd; 3rd and 3rd
generations respectively (Table 3). As far as the frequency
of BC concerns, this manifestation reveals to be focused on
2nd-degree/ 2nd-generation (i.e. mostly aunts), and 3rd-degree/
3rd-generation relatives (i.e. 1st cousins), however, again this
finding is explainable to some extend, by the fact that the
total number of relatives in the above-cited strata is expected
to be higher.
It is notable that in order to achieve the similar finding
in 3rd generation, we had to move one step further (2nd degree
to 3rd degree). But when we have a close look at 1st degree
relatives, we find almost similar frequencies in 2nd and 3rd
generations.
Considering the 1st generation relatives, grand parents
are relatively less involved, and that is the 3rd degree relatives
in 1st generation (mostly parents’ aunts) who show the most
involvement, similar to the distribution of afflicted 3rd
generation relatives (mostly probands’ aunts).
In addition, the least involvement in the probands’
generation (i.e. 3rd generation) was observed in 2nd degree
and 4th degree relatives. Meanwhile, involvement of 2nd
degree relatives was two-fold more than 4th degree relatives
in this generation (6/3) (Table 3).
Relatively low frequency of stepsibling due to second
marriages (2nd degree) in 3rd generation could be held
responsible for this alternative involvement pattern.
Regarding OMs, it was noted that 2nd generation relatives
(followed by 1st generation relatives) harbored the greatest
ratio of cancer involvement. In contrast, the 3rd generation
(which is representative of the most frequent BC
involvement) demonstrated less frequent involvement of
different types of OMs (table 4).
Standardized ratio of OM involvement in 2nd to 3rd
generation (0.17047/ 0.05149) is 3.31 (4.01, probands
included in the denominator) (Table 4). The same ratio for
BC (0.06419/0.03183) was 2.01 (0.69. probands included).
Considering parental lines, highest maternal to paternal (M/
P) ratios was observed for brain (2.7), uterus (2.8), followed
by colorectal (2.28) cancers. Excluding first degree relatives
(to minimize the possible effects of unequal sex ratio for
different cancers), highest M/P ratios was noted for Brain
(2.83), gastric (2.54), and colorectal (2.5) cancers. Therefore,
occurrence of brain tumors as the cancer with the highest
M/P ratio was predominant regardless of exclusion or
inclusion of the first degree relatives (Table 5).
When we considered the lowest M/P ratio (i.e. highest
P/M ratio), we noted that the prostate cancer (0.37), followed
by lung cancer (0.48) pose the minimum ratio. However
and excluding first degree relatives, the least M/P ratio was
noted for liver cancer (0.55). This finding demonstrates that
the majority of prostate cancer cases in our families were
occurred among 1st degree relatives (i.e. BC patients’ fathers)
(Table 5).
As far as distribution of OM’s across various generations
concerns, the most frequent cancers in 1st, 2nd, 3rd, and 4th
generations were gastric, gastric, uterus, and hematopoeitic
Table 9. The Number of Cancer Afflicted Relatives in
Total Studied Pedigrees.
Number   Frequency Percent  Valid Cumulative
of Cancers Percent     Percent
  .0 185 34.1 35.7 35.7
1.0 154 28.4 29.7 65.4
2.0 93 17.2 18.0 83.4
3.0 40 7.4 7.7 91.1
4.0 23 4.2 4.4 95.6
5.0 14 2.6 2.7 98.3
6.0 3 .6 .6 98.8
7.0 3 .6 .6 99.4
8.0 1 .2 .2 99.6
10.0 2 .4 .4 100.0
Total 518 95.6 100.0
Table 8. Mean Age of FH(+) and FH(-) Probands According to Type of Cancers.
              Gastric     Lung    Uterus     Leuk.      Brain     Color.      Eso.      Prost.     Liver   Lymph.  Ovary
FH(+) 48.36 49.41 51.81 52.13 47.71 50.29 51.77 54.65 49.04 52.91 53.57
FH(-) 49.20 49.09 48.91 48.88 49.21 49.05 48.97 48.83 49.12 48.94 49.06
Mean of Diff. -.846 0.322 2.905 3.246 -1.498 1.237 2.800 5.823 -.082 3.965 4.508
95% CI of  Diff. Lower -4.154 -3.047 -.834 -.491 -5.555 -3.158 -1.589 1.376 -4.927 -.765 -3.945
Upper  2.462  3.693  6.645 6.984  2.558 5.632 7.190 10.270  4.763 8.697 12.962
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system cancers respectively (Table 6). According to type of
cancers, the highest numbers (and highest frequency) of
gastric, lung, uterus, hematopoeitic system, brain, colorectal,
esophagus, prostate, and all cancers were noted in 2nd(1st),
2nd(2nd), 3rd(2nd), 4th(4th), 3rd(2nd), 2nd(2nd), 2nd(1st), 2nd(2nd), and
2nd(2nd) generations (Table 6).
Regarding OM distribution according to the degree of
relativity, highest number of gastric, lung, uterus, brain,
colorectal, esophagus, and prostate cancers was noted in 2nd,
1st, 2nd, equally 1st and 2nd, 3rd, 2nd, and 1st degree relatives
respectively (Table 7).
Conclusions
Family history (FH) of malignancies is one of the most
important, yet controversial risk factors of cancers, including
breast cancer (BC). In present study we tried to investigate
malignancies involvement pattern in relatives of 542 BC
patients.
Although the frequency of consanguineous marriages is
relatively high in Iran (14% in probands’ parents in present
study), there was no relation between consanguinity and
cancer incidence (data not presented here, see also Atri., et
al, 2002).
In our study, early-onset BC incidence was higher than
other studies performed in other populations (11.99%).
Unlike the previous reports linking early onset BC
occurrence and positive FH of BC, we found a less positive
FH ratio in our early-onset BC cases. To our surprise, we
had the highest numbers of isolated (non-familial) BC cases,
in patients who were younger than 36, or older than 70 years
old. The later can be explainable by the accommodation of
somatic genetic hits through the longer years, but the former
finding (together with the above-mentioned higher early-
onset BC occurrence in our population) raises the possibility
of environmental factor(s) affecting young females in Iran
and which predispose(s) them to an early-onset BC.
Age is considered as a general risk factor of malignancies.
In this study, we were facing the risk of a possible relation
between probands’ older age and more cancer occurrence
in relatives (due to relatives older age), which could
confound the analysis. Therefore, we compared the mean
age of the probands with and without family history of
cancers, and found that except for FH of prostate cancer,
there was no significant difference between mean age of
FH(+) and FH(-) probands. Also, mean age of the relatives
was independent of the mean age of the probands.
The highest frequency of BC was noted in 3rd generation,
followed by 2nd and 1st generations (with a decrement of
~1.5 fold). Thus, it would be expectable to witness an even
higher frequency in 4th generation, but the general younger
age of the relatives in this generation might have prevented
this to happen. This finding contradicts another expectation,
since BC incidence increases with age, and it would be
reasonable to have more BC cases in older generations.
Our analysis of the pedigrees revealed that the most BC-
involved relatives consist of aunts, first cousins, sisters, and
mothers respectively. However, considering the total number
of relatives in each of these categories, the order will change,
so that probands’ mothers and sisters become the most
involved relatives (data not presented here). Also, BC
involvement in maternal-line was associated with more
breast cancers in patients.
The most frequent OMs in our BC pedigrees were gastric,
lung, uterus, hematopoeitic system, brain and colorectal
cancers, which are rather in concordance with cancers in
general population, though considering BC, the later will
become the most frequent malignancy among BC pedigrees.
Also, excess of lung and uterus cancers in BC probands as
cited in other reports (Schildkraut et al., 1989; Peto et al.,
1996) was not confined to younger age groups in present
study.
When we compared the present population with the
Parses community (Persian Zoroastrians who fled to India
in 7th century AD), it was noted that incidence of lymphoma
in our population was much lower (data presented in 3rd
global cancer organizations conference, Brighton, UK,
2001). This finding, together with common genetic grounds
suggests some possible environmental factors leading to an
increased lymphoma incidence in that population.
Unlike BC, the highest frequency of OMs was noted in
2nd followed by 1st generations. Also, ratio of OM cases in
2nd to 3rd generations was much higher than the ratio of BC
cases in 2nd to 3rd generations.
Brain, gastric, and colorectal cancers (respectively)
tended to afflict maternal-line relatives much more than
paternal-line relatives. On the other hand, liver cancer was
the malignancy with most tendencies to afflict the paternal-
line relatives (1st degree relatives excluded). Also, majority
of prostate cancer cases were probands’ fathers.
Although gastric cancer was by far the most frequent
OM across pedigrees, uterus cancer, and hematopoeitic
system (leukemia) dominated over gastric cancer through
3rd and 4th generations respectively. Considering the rather
limited available information in 4th generation due to the
young age of relatives in this generation, dominancy of
leukemia is intriguing and therefore, BC involvement in
mothers might be put forward as a predictive factor for
developing leukemia in 4th generation. This hypothesis is
being tested in a case-control study.
Colorectal cancer is sometimes regarded as an
accompanying malignancy in BC pedigrees. Here, we found
out that the highest number of colorectal cancers were among
3rd degree relatives, mostly in maternal-line relatives, and
also in 2nd generation.
In line with the fact that gastric cancer was by far the
most frequent OM at all, it also dominated among 1st, 2nd,
and 3rd degree relatives. So far, most of the studies couldn’t
establish an evidence-based genetic frame for gastric cancer,
and this has redirected much attention towards environmental
factors. Our finding of a high frequency of gastric cancer in
our population might be attributable to high frequency of
this cancer in Iran, which requires more investigations. Just
as a descriptive note, it might be notable that the occurrence
Mehdipour P et al
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of lung, uterus, prostate and brain cancers in 1st degree
relatives was higher.This descriptive study reports on the
involvement pattern of malignancies in relatives of BC-
afflicted patients. Detailed analytic studies of these data is
being carried out and will be published subsequently.
